Influence of acute sleep deprivation on cardiovascular parameters in female zucker obese and lean rats

Obesity

Volumn 21, Issue 3, 2013, Pages 510-515

  Tenõrio, Neuli M ^a   Tufik, Sergio ^a   Bergamaschi, Cássia T ^a   Campos, Ruy R ^a   Cintra, Fátima ^a   Alvarenga, Tathiana A ^a   Andersen, Monica L ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

AGING; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; BRADYCARDIA; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; FEMALE; HEART RATE; LEAN BODY WEIGHT; MEAN ARTERIAL PRESSURE; NONHUMAN; OBESITY; PRESSORECEPTOR REFLEX; RAT; SLEEP DEPRIVATION; TACHYCARDIA;

ANIMALS; BAROREFLEX; BLOOD PRESSURE; BODY WEIGHT; BRADYCARDIA; CARDIOVASCULAR SYSTEM; FEMALE; HEART RATE; NITROPRUSSIDE; OBESITY; PHENYLEPHRINE; RATS; RATS, ZUCKER; SLEEP DEPRIVATION; TACHYCARDIA;

ANIMALIA; RATTUS;

EID: 84876481511     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20063     Document Type: Article

References (39)

1. Knutson KL, Lauderdale DS,. Sleep duration and overweight in adolescents: self-reported sleep hours versus time diaries. Pediatrics 2007; 119: 1056-1062.
2. Javaheri S, Storfer-Isser A, Rosen CL, et al. Sleep quality and elevated blood pressure in adolescents. Circulation 2008; 118: 1034-1040.
3. Patel SR, Malhotra A, White DP, et al. Association between reduced sleep and weight gain in women. Am J Epidemiol 2006; 164: 947-954.
4. Gutierrez DA, Puglisi MJ, Hasty AH,. Impact of increase adipose tissue mass on inflammation, insulin resistance and dyslipidemia. Curr Diab Rep 2009; 9: 26-32.
5. Kobalava ZD, Villeval de SV, Isikova KV,. The role of adiponectin in development and progression of cardiovascular diseases. Kardiologia 2009; 49: 51-58.
6. Shamsuzzaman ASM, Caples SM, Somers VK,. Sleep deprivation and circulatory control. Sleep 2003; 26: 934-936.
7. Everson CA, Laatsch CD, Hogg N,. Antioxidant defense responses to sleep loss and sleep recovery. Am J Physiol Regul Integr Comp Physiol 2005; 288: 374-383.
8. Lohmeier TE, Hildebrandt DA, Warren S, et al. Recent insights into the interactions between the baroreflex and the kidneys in hypertension. Am J Physiol Regul Integ Comp Physiol 2005; 288: 828-836.
9. Lohmeier TE, Barrett AM, Irwin ED,. Prolonged activation of the baroreflex: a viable approach for the treatment of hypertension? Curr Hypertens Rep 2005; 7: 193-198.
10. Benca RM, Schenck CH,. Sleep and eating disorders. In:, Kryger MH, Roth T, Dement WC, editors. Principles and practices of sleep medicine. Philadelphia: Elsevier, 2005, pp 1337-1344.
11. Lima DC, Silveira AS, Haibara AS, et al. The enhanced hyperglycemic response to hemorrhage hypotension in obese rats is related to an impaired baroreflex. Metab Brain Dis 2008; 23: 361-373.
12. Kaye DM, Esler MD,. Autonomic control of the aging heart. Neuromolecular Med 2008; 10: 179-186.
13. Di Nardo F, Burattini R, Cogo CE, et al. Age-related analysis of insulin resistance, body weight and arterial pressure in the Zucker fatty rat. Exp Physiol 2009; 94: 162-168.
14. Johnson FK, Johnson RA, Durante W, et al. Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 2006; 290: 601-608.
15. Argilés, JM,. The obese Zucker rat: a choice for fat metabolism. Prog Lipid Res 1989; 28: 53-66.
16. Bray GA,. The Zucker-fatty rat: a review. Federation Proc 1977; 36: 148-153.
17. Andersen ML, D'Almeida V, Ko GM, et al. Princípios éticos e práticos do uso de animais de laboratõrio. São Paulo: Universidade Federal de São Paulo, 2004, pp 18-33.
18. Papale LA, Paul KN, Sawyer NT, et al. Dysfunction of the Scn8a voltage-gated sodium channel alters sleep architecture, reduces diurnal corticosterone levels, and enhances spatial memory. J Biol Chem 2010; 285: 16553-16561.
19. Antunes IB, Andersen ML, Baracat EC, et al. The effects of paradoxal sleep deprivation on estrous cycles of the female rats. Horm Behav 2006; 49: 433-440.
20. Hofmann KL, Mussgay L, Ruddel H,. Autonomic cardiovascular regulation in obesity. J Endocrinol 2000; 164: 59-66.
21. Hubert HB, Feinleib M, MacNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-977.
22. Hirsch J, Leibel R, Mackintosh R, et al. Heart rate variability as a measure of autonomic function during weight change in humans. Regul Int Compreh Physiol 1991; 30: 1418-1423.
23. Jin X, Fukuda N, Su J, et al. Effects of leptin on endothelial function with OB-Rb gene transfer in Zucker fatty rats. Atherosclerosis 2003; 169: 225-233.
24. Rivera L, Morõn R, Zarzuelo A, et al. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 2009; 77: 1053-1063.
25. Hall JE, Hildebrandt DA, Kuo J,. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens 2001; 14: 103S-115S.
26. Van Dijk G, Thiele TE, Donahey JC, et al. Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain. Am J Physiol Regul Integr Comp Physiol 1996; 27: R1096-R1100.
27. Dunbar JC, Hu Y, Lu H,. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997; 46: 2040-2043.
28. Grassi G,. Leptin, sympathetic nervous system, and baroreflex function. Curr Hypertens 2004; 6: 236-240.
29. Copinschi G,. Metabolic and endocrine effects of sleep deprivation. Essent Psychopharmacol 2005; 6: 341-347.
30. Laposky AD, Bradley MA, Williams DL, et al. Sleep-wake regulation is altered in leptin-resistant (db/db) genetically obese and diabetic mice. Am J Physiol Regul Integr Comp Physiol 2008; 295: 2059-2066.
31. Beccuti G, Pannain S,. Sleep and obesity. Curr Opin Clin Nutr Metab Care 2011; 14: 402-412.
32. Taheri S, Lin L, Austin D, et al. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004; 1: e62.
33. Gangwisch JE, Malaspina D, Boden-Albala B, et al. Inadequate sleep as a risk factor for obesity: analyses of the NHANES. Sleep 2005; 28: 1289-1296.
34. Chaput JP, Brunet M, Tremblay A,. Relationship between short sleeping hours and childhood overweight/obesity: results from the 'Quebec en Forme' Project. Int J Obes 2006; 30: 1080-1085.
35. Méier-Ewert HK, Ridker PM, Rifai N, et al. Effect of sleep loss on C-reative protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004; 43: 678-683.
36. Esler M, Straznicky N, Eikelis N, et al. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 2006; 48: 1-10.
37. Mortara A, Rovere MTL, Pinna GD, et al. Arterial baroreflex modulation of heart rate in chronic heart failure. Circulation 1997; 96: 3450-3458.
38. Head GA, Adams MA,. Characterization of the baroreceptor heart rate reflex during development in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1992; 19: 587-597.
39. Lohmeier TE, Dwyer TM, Irwin ED, et al. Prolonged activation of the baroreflex abolishes obesity-induced hypertension. Hypertension 2007; 49: 1307-1314.